68
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T22223 |
3PO
|
Glucokinase; Autophagy | Autophagy; Metabolism |
3PO 是一种 PFKFB3 的小分子抑制剂,IC50值为22.9 μM。它抑制几种人类恶性造血和腺癌细胞系的增殖,IC50在1.4到24 μM 之间。它抑制葡萄糖摄取,并降低 Fru-2,6-BP、乳酸、ATP、NAD+ 和 NADH 的细胞内浓度。 | |||
T2121 |
SW033291
|
Dehydrogenase | Metabolism |
SW033291 是有效的15-PGDH 抑制剂,与15-PGDH 亲和力高,Ki 为 0.1 nM。它增加骨髓和其他组织中前列腺素 PGE2 的水平。它还可促进组织再生。 | |||
T11438 |
GNE-1858
|
Others; MAPK | MAPK; Others |
GNE-1858 是高效的 ATP 竞争性造血祖细胞激酶-1抑制剂,能够抑制野生型(IC50:1.9 nM)、活性模拟突变株 HPK1-TSEE (IC50:1.9 nM)、 HPK1-SA (IC50:4.5 nM)的活性。 | |||
T69730 |
F092 inhibitor
|
||
F092 inhibitor, also called Prostaglandin D synthase (hematopoietic-type) inhibitor F092, is an inhibitor of hematopoietic-type prostaglandin D synthase (H-PGDS). | |||
T3590 |
NSC23005
|
CDK | Cell Cycle/Checkpoint |
NSC23005 是一种 p18INK 抑制剂,可有效促进造血干细胞 (HSC) 扩增 (ED50: 5.21 nM)。 | |||
T1776L |
Plerixafor octahydrochloride
盐酸普乐沙福,JM3100 octahydrochloride,Plerixafor 8HCl (AMD3100 8HCl),Plerixafor 8HCl,SID791 octahydrochloride,AMD 3100 octahydrochloride,JM 3100 8HCl |
Virus Protease; HIV Protease; CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation; Microbiology/Virology; Proteases/Proteasome |
Plerixafor octahydrochloride (JM3100 octahydrochloride) 是一种选择性的CXCR4拮抗剂,IC50为 44 nM。Plerixafor 是一种具有造血干细胞动员活性的双环霉素。 | |||
T8883 |
Pizuglanstat
|
Others; Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation; Others |
Pizuglanstat 是一种前列腺素 D 合酶抑制剂,对人造血前列腺素 D 合酶的IC50为 76 nM,可用于肌再生性疾病研究。 | |||
T7948 |
HPGDS inhibitor 2
GSK-2894631A |
PGE Synthase | Immunology/Inflammation |
HPGDS inhibitor 2 (GSK-2894631A) 是高效的造血前列腺素 D 合成酶(H-PGDS)选择性抑制剂(IC50:9.9 nM)。 | |||
T24580 |
P18IN003
P18IN 003,P18IN-003 |
CDK | Cell Cycle/Checkpoint |
P18IN003 是一种具有选择性和有效性的 p18(INK4C) 抑制剂,可抑制 p18 蛋白的活性可用于研究造血干细胞的体外扩增。 | |||
T16699 |
PYZD-4409
|
Others; E1/E2/E3 Enzyme | Others; Ubiquitination |
PYZD-4409 是一种特异性 UBA1 抑制剂,IC50 为 20 μM。 PYZD-4409 在恶性细胞中诱导细胞死亡,并且对恶性细胞的细胞毒性优于对正常造血细胞的细胞毒性。 | |||
T3589 |
NSC23005 Sodium
|
CDK | Cell Cycle/Checkpoint |
NSC23005 sodium 是新型 p18 抑制剂 (ED50=5.21 nM),在小鼠和人类模型中促进造血干细胞扩增。 | |||
T21785 |
AG957
|
Bcr-Abl | Angiogenesis; Cytoskeletal Signaling; Tyrosine Kinase/Adaptors |
Tyrphostin AG957 是一种酪氨酸激酶抑制剂,具有抗BCR/ABL 酪氨酸激酶活性。它能够抑制p210bcr/abl 酶活性 (IC50:2.9 μM)。 | |||
T1804 |
HPGDS inhibitor 1
HPGDS-inhibitor-1 |
PGE Synthase | Immunology/Inflammation |
HPGDS inhibitor 1 是口服具有活性的HPGDS 选择性抑制剂,在酶和细胞分析中的IC50值分别为 0.6 nM 和 32 nM,但对 L-PGDS、mPGES、COX-1、COX-2 、5-LOX 无抑制作用。 | |||
T60081 |
BV02
2-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-1,3-dioxoisoindoline-5-carboxylic acid |
Others | Others |
BV02 是 14-3-3 蛋白-蛋白相互作用的抑制剂,可用于治疗慢性粒细胞白血病的研究。 BV02 破坏表达 IM 抗性 T315I 突变和 IM 敏感的野生型 Bcr-Abl 的造血细胞。 | |||
T8836 |
CY5-SE triethylamine salt
Fluorolink Cy5 triethanolamine salt,Cy5-SE (triethylamine salt) |
Others | Others |
CY5-SE triethylamine salt (Fluorolink Cy5 triethanolamine salt) 是一种用于标记肽, 蛋白质, 寡核苷酸的氨基基团的反应染料 (Ex=649 nm; Em=670 nm)。 | |||
T11053 |
DJ001
|
Phosphatase | Metabolism |
DJ001 是一种高度特异性,选择性和非竞争性的蛋白酪氨酸磷酸酶-σ (PTPσ) 抑制剂,IC50 为 1.43 μM。DJ001 对其他磷酸酶无抑制活性,对蛋白质磷酸酶 5 仅有中等抑制活性。DJ001 促进造血干细胞再生。 | |||
T9017 |
HPK1-IN-2
Thieno[2,3-b]pyridin-6(7H)-one, 4-amino-5-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-HPK1-IN-2,HPK1-IN-2 |
Others; FLT; Src | Angiogenesis; Others; Tyrosine Kinase/Adaptors |
HPK1-IN-2 (Thieno[2,3-b]pyridin-6(7H)-one, 4-amino-5-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-HPK1-IN-2) 是一种有效且具有口服活性的造血祖细胞激酶-1 抑制剂(HPK1;IC50<0.05 µM)。它还抑制 Lck (0.05 µM<IC50<0.5 µM) 和 Flt3 (IC50<0.05 µM) 激酶活性,具有抗肿瘤活性。 | |||
T76870 |
Narsoplimab
OMS 721 |
SARS-CoV | Microbiology/Virology |
Narsoplimab (OMS 721) 是一种选择性全人免疫球蛋白γ 4 (IgG4) 单克隆抗体,是一种甘露聚糖结合凝集素相关的丝氨酸蛋白酶-2(MASP-2)抑制剂,可结合 MASP-2 并阻止凝集素通路激活,对凝集素通路有抑制作用。Narsoplimab 可用于研究成人造血干细胞移植相关疾病。 | |||
T22070 |
DBIBB
|
LPA Receptor | GPCR/G Protein |
DBIBB 是一种特异性溶血磷脂酸 (LPA2) 的 2 型 G 蛋白偶联受体的非脂质激动剂,是一种能够治疗高强度γ 射线对造血和胃肠系统引起的急性放射综合征的潜在活性分子 ,是一种作未有机合成和药物研究中的中间体。 DBIBB 可用于制备各种化合物,可减轻胃肠道辐射综合征,增加肠隐窝存活率和肠细胞增殖,并减少细胞凋亡 。 | |||
T21493 |
Cyclosporin H
|
Others | Others |
Cyclosporin H 是一种 FPR-1(甲酰肽受体 1) 的选择性强效抑制剂。它缺乏 Cyclosporin A 具有的免疫抑制活性。它是一种病毒转导增强剂,可使人脐带血来源的造血干细胞和祖细胞中慢病毒转导增强 10 倍。它与雷帕霉素或前列腺素 E2 联合使用时表现出累加效应。 | |||
T24870 |
TFC-007
TFC007 |
||
TFC-007 is an inhibitor of hematopoietic prostaglandin D synthase. | |||
T39709 |
HPK1-IN-19
HPK1-IN-19 |
||
HPK1-IN-19 is an inhibitor of hematopoietic progenitor kinase 1 (HPK1). | |||
T40188 |
HPK1-IN-20
HPK1-IN-20 |
||
HPK1-IN-19 is a potent inhibitor of hematopoietic progenitor kinase 1 (HPK1). | |||
TP2339 |
Goralatide
|
||
Goralatide, isolated from fetal calf bone marrow, exerts a high inhibitory activity on the proliferation of hematopoietic pluripotent stem cells. | |||
T29166 |
XIE18-6
XIE186 |
||
XIE18-6, a novel INK4C inhibitor, specifically blocks the bioactivity of p18 protein and promotes human and murine hematopoietic stem cell ex vivo expansion. | |||
T26887 |
BOP
|
||
BOP is anantagonist of alpha4beta1/alpha9beta1 integrins. BOP rapidly mobilizes long-term multi-lineage reconstituting hematopoietic stem cells (HSC). | |||
T27591 |
II-B08
II-B 08,FAP1 Inhibitor,II-B-08,LMWPTP Inhibitor,Lyp Inhibitor III,CD45 Inhibitor V |
||
II-B08 is a cell-permeable SHP2 inhibitor (IC50 = 5.5 µM). II-B08 blocks growth factor stimulated ERK1/2 activation and hematopoietic progenitor proliferation. | |||
T10046 |
16,16-Dimethyl prostaglandin E2
16,16-dimethyl PGE2 |
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
16,16-Dimethyl prostaglandin E2 is an orally active vertebrate Hematopoietic stem cells homeostasis critical regulator. It can act through EP2/EP4 and has an interaction with the Wnt pathway. | |||
T37603 |
Osteogenic Growth Peptide (10-14)
|
||
YGFGG, C-terminal pentapeptide fragment of the osteogenic growth peptide (OGP), (H-8640), showed the full spectrum of OGP-like bioactivities. It has attracted considerable interest as bone anabolic agent and hematopoietic stimulator. | |||
T72052 |
HPK1-IN-34
|
||
HPK1-IN-34是一种造血祖细胞激酶1(HPK1)抑制剂,IC50<100nM。 | |||
T72036 |
HPK1-IN-36
|
Others | Others |
HPK1-IN-36(compound 2)作为一种HPK1抑制剂,表现出高效性,其IC50为0.5 nM。 | |||
T33267 |
Me6TREN 4HCl
Me6TREN Tetrahydrochloride,Me6-TREN Tetrahydrochloride,Me6 4HCl,Me 6 4HCl,Me-6 4HCl |
||
Me6TREN 4HCl is a potent and efficacious mobilizing agent of hematopoietic stem and progenitor cells (HSPCs) that can act by activating MMP-9 expression and disrupting the SDF-1α/CXCR4 axis, exhibiting more significant mobilizing effects than G-CSF or AMD | |||
T77993 |
Goralatide acetate
|
||
Goralatide为一种内源性四肽,作为造血生理调节剂。该化合物能够抑制原始造血细胞的增殖。 | |||
T62859 | MEIS-IN-1 | ||
MEIS-IN-1 是一种有效的诱导小鼠和人类造血干细胞扩增的 MEIS 抑制剂。 | |||
T63046 |
HPK1-IN-15
|
||
HPK1-IN-15 是一种选择性的、有效的 HPK1 抑制剂。其中从造血祖细胞克隆的造血祖细胞激酶1 (HPK1) 属于 MAP4Ks 家族。HPK1-IN-15 能够用于与 HPK1 活性相关的疾病或病症 (如癌症) 的研究、预防或改善。 | |||
T62547 |
HPK1-IN-17
|
||
HPK1-IN-17 是一种选择性的、有效的 HPK1 抑制剂。造血祖细胞激酶1 (HPK1) 是 MAP4Ks 的家族成员,从造血祖细胞克隆。HPK1-IN-17 能够用于研究、预防或改善与 HPK1 活性相关的疾病或病症(如癌症)。 | |||
TP2141L |
Balixafortide
POL6326 |
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
Balixafortide (POL6326) is a potent, selective, well-tolerated peptidic CXCR4 antagonist with an IC50 < 10 nM and it is also a potent hematopoietic stem and progenitor cell (HSPC) mobilizing agent. Anti-cancer effects[1][2]. Balixafortide blocks β-arresti | |||
T15503 |
HQL-79
|
Others | Others |
HQL-79 is a selective and orally active human hematopoietic prostaglandin D synthase (H-PGDS) inhibitor. It inhibits the synthesis of PGD2 and acts as an anti-allergic agent (Kd: 0.8 μM and IC50: 6 μM). It also shows no obvious effect on COX-1, COX-2, m-P | |||
T13627 |
CP-10
|
CDK | Cell Cycle/Checkpoint |
CP-10 is a PROTAC with highly selective and remarkable CDK6 degradation (DC50: 2.1 nM). It inhibits the proliferation of several hematopoietic cancer cells including multiple myeloma and can degrade mutated and overexpressed CDK6. | |||
T60973 |
HPK1-IN-24
|
||
HPK1-IN-24 (example 51) 可用于癌症领域研究,它是造血祖细胞激酶 1 (HPK1)的抑制剂 (Ki = 100 nM)。 | |||
T78852 |
HPK1-IN-39
|
||
HPK1-IN-39(Compound 10n)为一选择性HPK1抑制剂,IC50值为29 nM。该化合物能抑制SLP76磷酸化,可用于癌症免疫治疗研究。 | |||
T61449 | HPK1-IN-18 | ||
HPK1-IN-18 is a highly effective and specific HPK1 inhibitor. HPK1, a MAP kinase kinase kinase kinases (MAP4K) member, was initially isolated from hematopoietic progenitor cells. This compound, known as HPK1-IN-18, is valuable for investigating, preventing, or managing diseases or conditions linked to HPK1 activity, such as cancer[1]. | |||
T61733 |
HPK1-IN-25
|
||
HPK1-IN-25 (示例 94) 为一种造血祖细胞激酶1 (HPK1) 抑制剂,具有129 nM的IC50值,展现出在癌症研究中的潜力。 | |||
T63661 |
HF51116
|
||
HF51116 是 XCR4 的有效拮抗剂。HF51116 能够显著拮抗 SDF-1α 诱导的细胞迁移、钙动员和 CXCR4 内化,并利用 CXCR4 抑制 HIV-1 感染。HF51116 对HIV-1感染、造血干细胞动员和癌症转移表现出研究潜力。 | |||
T76748 | Foralumab | ||
Foralumab(NI-0401)为口服有效的人源化单克隆抗体,针对CD3进行靶向。其能够调控NSG小鼠体内,由人类造血干细胞重建的人类细胞的免疫反应。 | |||
T36545 |
Prostaglandin D2 methyl ester
Prostaglandin D2 methyl ester |
||
Prostaglandin D2 (PGD2) is the major eicosanoid product of mast cells and is produced in large quantities by hematopoietic PGD synthase during allergic and asthmatic anaphylaxis. It causes vasodilation, flushing, hypotension, and is an inhibitor of platelet aggregation. Prostaglandin D2 methyl ester (PGD2 methyl ester) is a more lipid-soluble, cell-permeable prodrug form of PGD2. It binds to the human and mouse PGD2 receptors (DP1 and CRTH2/DP2) with 5-10 fold lower affinity than PGD2. | |||
T75752 |
N-Acetyl-Ser-Asp-Lys-Pro acetate
|
||
N-Acetyl-Ser-Asp-Lys-Pro (Ac-SDKP) acetate 是血管紧张素转换酶 (ACE) N 端活性位点的特异性底物。N-Acetyl-Ser-Asp-Lys-Pro acetate 是多能干细胞增殖的天然抑制剂。N-Acetyl-Ser-Asp-Lys-Pro acetate 具有抗炎和抗纤维化特性。 | |||
T61250 | HPGDS inhibitor 3 | ||
HPGDS inhibitor 3 is a powerful oral compound that selectively inhibits the hematopoietic prostaglandin D synthase (H-PGDS). With an IC50 value of 9.4 nM and EC50 of 42 nM, it demonstrates high potency in peripherally restricting H-PGDS. Moreover, HPGDS inhibitor 3 exhibits excellent selectivity with no associated central nervous system toxicity. This compound also possesses favorable pharmacokinetic properties in mouse, rat, and dog models. Additionally, HPGDS inhibitor 3 displays noteworthy an... | |||
T63659 | HPK1-IN-10 | ||
HPK1-IN-10 是 HPK1 的有效抑制剂。HPK1 是一种丝氨酸/苏氨酸蛋白激酶,由造血祖细胞克隆得到,是哺乳动物Ste-20相关蛋白激酶MAP4K 家族成员之一。HPK1-IN-10 对HPK1 相关疾病具有研究潜力。 | |||
T36296 | BIO5192 hydrate | ||
BIO5192 hydrate is a selective and potent integrin α4β1 (VLA-4) inhibitor (Kd<10 pM). BIO5192 hydrate selectively binds to α4β1 (IC50=1.8 nM) over a range of other integrins. BIO5192 hydrate results in a 30-fold increase in mobilization of murine hematopoietic stem and progenitors (HSPCs) over basal levels[1][2]. The combination of BIO5192 hydrate (1 mg/kg; i.v.) and Plerixafor (5 mg/kg; s.c.) exert an additive effect on progenitor mobilization[1].BIO5192 hydrate (30 mg/kg; s.c; bid; during days... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN2883 |
3',4'-Dimethoxyflavone
|
Others; PARP | Chromatin/Epigenetic; DNA Damage/DNA Repair; Others |
3',4'-Dimethoxyflavone 是类黄酮化合物的参考标准,类黄酮化合物具有多种药用活性。 | |||
T31836 |
Folate sodium
Folic acid, monosodium salt,Folvite sodium |
||
Folate sodium, as a member of the vitamin B family, can stimulate the hematopoietic system. Folic acid can be used in the treatment and prevention of folate deficiencies and megaloblastic anemia. | |||
TN5094 |
Tangshenoside I
|
Glucokinase | Metabolism |
Tangshenoside I might be a potential bioactive marker related to the hematopoietic and immunologic functions of Codonopsis Radix, which could be recommended as the index compound. It has α-glucosidase inhibition activity. |